The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Takuya Fukazawa

Department of General Surgery

Kawasaki Medical School

Okayama 700-8505

Japan

[email]@aol.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of General Surgery, Kawasaki Medical School, Okayama 700-8505, Japan. 2010
  • Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan. 2007 - 2010
  • Department of Biomedical Sciences, University of California, Riverside, California, USA. 2004

References

  1. Targeting KRAS mutation-bearing lung cancer in vivo by pulmonary surfactant-adenovirus-mediated gene transfer. Fukazawa, T., Maeda, Y., Matsuoka, J., Ono, T., Mominoki, K., Yamatsuji, T., Shigemitsu, K., Morita, I., Murakami, I., Tanaka, H., Durbin, M.L., Naomoto, Y. Anticancer Res. (2010) [Pubmed]
  2. Inhibition of Myc effectively targets KRAS mutation-positive lung cancer expressing high levels of Myc. Fukazawa, T., Maeda, Y., Matsuoka, J., Yamatsuji, T., Shigemitsu, K., Morita, I., Faiola, F., Durbin, M.L., Soucek, L., Naomoto, Y. Anticancer Res. (2010) [Pubmed]
  3. Adenovirus-mediated cancer gene therapy and virotherapy (Review). Fukazawa, T., Matsuoka, J., Yamatsuji, T., Maeda, Y., Durbin, M.L., Naomoto, Y. Int. J. Mol. Med. (2010) [Pubmed]
  4. Drug-regulatable cancer cell death induced by BID under control of the tissue-specific, lung cancer-targeted TTS promoter system. Fukazawa, T., Maeda, Y., Matsuoka, J., Tanaka, N., Tanaka, H., Durbin, M.L., Naomoto, Y. Int. J. Cancer (2009) [Pubmed]
  5. Malignant pleural mesothelioma-targeted CREBBP/EP300 inhibitory protein 1 promoter system for gene therapy and virotherapy. Fukazawa, T., Matsuoka, J., Naomoto, Y., Maeda, Y., Durbin, M.L., Tanaka, N. Cancer Res. (2008) [Pubmed]
  6. Pulmonary adenocarcinoma-targeted gene therapy by a cancer- and tissue-specific promoter system. Fukazawa, T., Maeda, Y., Durbin, M.L., Nakai, T., Matsuoka, J., Tanaka, H., Naomoto, Y., Tanaka, N. Mol. Cancer Ther. (2007) [Pubmed]
  7. Development of a cancer-targeted tissue-specific promoter system. Fukazawa, T., Maeda, Y., Sladek, F.M., Owen-Schaub, L.B. Cancer Res. (2004) [Pubmed]
 
WikiGenes - Universities